Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age

OBJECTIVES: Levodopa–Carbidopa Intrajejunal gel (LCIG) infusion is an effective intervention for people with advanced Parkinson’s disease (PD). Although age may not be a limiting factor for LCIG implant, no data are available on late elderly PD (LE-PD) subjects. In this cross-sectional, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgante, Francesca, Oppo, Valentina, Fabbri, Margherita, Olivola, Enrica, Sorbera, Chiara, De Micco, Rosa, Ielo, Giovanna Chiara, Colucci, Fabiana, Bonvegna, Salvatore, Novelli, Alessio, Modugno, Nicola, Sensi, Mariachiara, Zibetti, Maurizio, Lopiano, Leonardo, Tessitore, Alessandro, Pilleri, Manuela, Cilia, Roberto, Elia, Antonio E., Eleopra, Roberto, Ricciardi, Lucia, Cossu, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068706/
https://www.ncbi.nlm.nih.gov/pubmed/33354739
http://dx.doi.org/10.1007/s00415-020-10356-x

Ejemplares similares

Ejemplares similares